Get latest articles and stories on India at LatestLY. Homegrown pharma majors Sun Pharma, Cipla, Hetero and Torrent on Tuesday announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with COVID-19 across India shortly. India News | Pharma Players to Launch Anti-Covid Pill Molnupiravir Shortly After DCGI Approval.
Homegrown pharmaceutical majors Sun Pharma, Cipla, Hetero and Torrent on Tuesday announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with Covid-19 across India shortly.
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
Pharma players to launch anti-Covid pill Molnupiravir shortly after DCGI approval dtnext.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtnext.in Daily Mail and Mail on Sunday newspapers.